| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Amyloid beta-Peptides | 80 | 2024 | 3787 | 5.700 |
Why?
|
| Alzheimer Disease | 97 | 2024 | 8412 | 5.610 |
Why?
|
| Alzheimer Vaccines | 12 | 2020 | 25 | 4.390 |
Why?
|
| Amyloid beta-Protein Precursor | 30 | 2024 | 1101 | 2.950 |
Why?
|
| Plaque, Amyloid | 25 | 2022 | 742 | 2.750 |
Why?
|
| Pyrrolidonecarboxylic Acid | 7 | 2021 | 65 | 2.430 |
Why?
|
| Mice, Transgenic | 39 | 2024 | 9460 | 2.030 |
Why?
|
| Presenilin-1 | 18 | 2024 | 646 | 1.910 |
Why?
|
| Gamma Rays | 2 | 2024 | 316 | 1.590 |
Why?
|
| Down Syndrome | 14 | 2021 | 882 | 1.570 |
Why?
|
| Iron Radioisotopes | 2 | 2021 | 19 | 1.500 |
Why?
|
| Peptide Fragments | 24 | 2021 | 5073 | 1.370 |
Why?
|
| Complement C3 | 3 | 2017 | 449 | 1.220 |
Why?
|
| Immunization, Passive | 7 | 2020 | 610 | 1.190 |
Why?
|
| Aging | 17 | 2024 | 8573 | 1.160 |
Why?
|
| Disease Models, Animal | 35 | 2024 | 17960 | 1.130 |
Why?
|
| Cosmic Radiation | 2 | 2024 | 19 | 1.070 |
Why?
|
| Microglia | 11 | 2023 | 1322 | 1.050 |
Why?
|
| Hippocampus | 14 | 2024 | 3708 | 1.000 |
Why?
|
| Immunization | 8 | 2013 | 1219 | 0.950 |
Why?
|
| Brain | 44 | 2024 | 26820 | 0.910 |
Why?
|
| Immunotherapy | 11 | 2020 | 4601 | 0.770 |
Why?
|
| Insulysin | 2 | 2020 | 49 | 0.750 |
Why?
|
| Antibody Formation | 11 | 2013 | 1381 | 0.700 |
Why?
|
| Nerve Degeneration | 3 | 2017 | 742 | 0.700 |
Why?
|
| Antibodies, Monoclonal | 8 | 2024 | 9107 | 0.700 |
Why?
|
| Blood-Brain Barrier | 5 | 2022 | 1014 | 0.690 |
Why?
|
| Animals | 90 | 2024 | 166825 | 0.680 |
Why?
|
| Mice | 54 | 2024 | 80551 | 0.630 |
Why?
|
| Neuroglia | 5 | 2020 | 940 | 0.620 |
Why?
|
| Gliosis | 5 | 2017 | 245 | 0.610 |
Why?
|
| Cognition Disorders | 7 | 2016 | 3974 | 0.600 |
Why?
|
| Behavior, Animal | 4 | 2021 | 1853 | 0.600 |
Why?
|
| Antibodies | 11 | 2016 | 2413 | 0.580 |
Why?
|
| Amyloid | 6 | 2021 | 822 | 0.560 |
Why?
|
| Neuroprotective Agents | 6 | 2013 | 955 | 0.560 |
Why?
|
| Space Flight | 1 | 2019 | 202 | 0.560 |
Why?
|
| Sesquiterpenes | 2 | 2007 | 175 | 0.530 |
Why?
|
| Benzofurans | 3 | 2010 | 140 | 0.490 |
Why?
|
| Sex Characteristics | 2 | 2024 | 2614 | 0.490 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 14 | 2015 | 3781 | 0.480 |
Why?
|
| Carbazoles | 1 | 2015 | 220 | 0.470 |
Why?
|
| Synapses | 10 | 2018 | 1745 | 0.450 |
Why?
|
| Vaccination | 5 | 2019 | 3321 | 0.450 |
Why?
|
| Receptors, GABA | 1 | 2015 | 310 | 0.450 |
Why?
|
| Diphtheria Toxoid | 1 | 2013 | 26 | 0.450 |
Why?
|
| Complement System Proteins | 3 | 2024 | 780 | 0.450 |
Why?
|
| Phagocytosis | 5 | 2020 | 1527 | 0.440 |
Why?
|
| Mice, Inbred C57BL | 18 | 2019 | 21724 | 0.430 |
Why?
|
| Complement C3c | 1 | 2012 | 7 | 0.420 |
Why?
|
| Fluorine Radioisotopes | 1 | 2015 | 449 | 0.420 |
Why?
|
| Macrophage-1 Antigen | 2 | 2016 | 286 | 0.410 |
Why?
|
| Immunoglobulin G | 8 | 2022 | 4520 | 0.390 |
Why?
|
| Apolipoprotein E4 | 3 | 2024 | 687 | 0.390 |
Why?
|
| Heart | 1 | 2024 | 4374 | 0.380 |
Why?
|
| Maze Learning | 5 | 2015 | 477 | 0.370 |
Why?
|
| Vaccines | 5 | 2006 | 830 | 0.360 |
Why?
|
| Epigenesis, Genetic | 3 | 2019 | 3705 | 0.360 |
Why?
|
| Complement Activation | 2 | 2024 | 444 | 0.350 |
Why?
|
| Adjuvants, Immunologic | 3 | 2005 | 1026 | 0.350 |
Why?
|
| Antibody Specificity | 5 | 2006 | 1060 | 0.340 |
Why?
|
| Dose-Response Relationship, Radiation | 2 | 2023 | 873 | 0.340 |
Why?
|
| Antigens | 2 | 2009 | 1439 | 0.330 |
Why?
|
| Kidney | 2 | 2024 | 6985 | 0.330 |
Why?
|
| Saguinus | 1 | 2008 | 13 | 0.320 |
Why?
|
| Mice, Inbred DBA | 5 | 2019 | 612 | 0.300 |
Why?
|
| Enterotoxins | 3 | 2006 | 365 | 0.300 |
Why?
|
| Genotype | 2 | 2021 | 12869 | 0.290 |
Why?
|
| Administration, Intranasal | 7 | 2006 | 472 | 0.290 |
Why?
|
| Central Nervous System | 3 | 2024 | 1331 | 0.290 |
Why?
|
| Cognition | 4 | 2021 | 6862 | 0.280 |
Why?
|
| Epitope Mapping | 4 | 2013 | 297 | 0.270 |
Why?
|
| Neurons | 15 | 2017 | 9352 | 0.270 |
Why?
|
| Humans | 92 | 2024 | 752810 | 0.260 |
Why?
|
| Escherichia coli Proteins | 4 | 2006 | 1052 | 0.250 |
Why?
|
| Minocycline | 1 | 2006 | 169 | 0.250 |
Why?
|
| Cerebral Cortex | 10 | 2017 | 5729 | 0.240 |
Why?
|
| Bacterial Toxins | 3 | 2006 | 930 | 0.230 |
Why?
|
| Cerebral Amyloid Angiopathy | 4 | 2024 | 879 | 0.230 |
Why?
|
| Protein Processing, Post-Translational | 4 | 2020 | 1953 | 0.220 |
Why?
|
| Apolipoproteins E | 3 | 2023 | 1430 | 0.220 |
Why?
|
| Nerve Tissue Proteins | 6 | 2012 | 4411 | 0.220 |
Why?
|
| Male | 41 | 2024 | 355160 | 0.220 |
Why?
|
| Memory Disorders | 3 | 2018 | 1185 | 0.220 |
Why?
|
| Neurofibrillary Tangles | 5 | 2016 | 450 | 0.210 |
Why?
|
| Imidazolines | 1 | 2021 | 18 | 0.200 |
Why?
|
| Complement C1q | 4 | 2020 | 94 | 0.200 |
Why?
|
| Immunity, Cellular | 2 | 2005 | 1541 | 0.200 |
Why?
|
| Statistics, Nonparametric | 3 | 2013 | 2844 | 0.200 |
Why?
|
| Cytokines | 6 | 2017 | 7239 | 0.200 |
Why?
|
| Neuronal Plasticity | 5 | 2015 | 1431 | 0.190 |
Why?
|
| Aminoacyltransferases | 1 | 2021 | 51 | 0.190 |
Why?
|
| Interleukin-1beta | 1 | 2007 | 996 | 0.190 |
Why?
|
| Amyloid Precursor Protein Secretases | 7 | 2007 | 601 | 0.190 |
Why?
|
| Cathepsins | 4 | 2004 | 241 | 0.190 |
Why?
|
| tau Proteins | 5 | 2016 | 2044 | 0.190 |
Why?
|
| MAP Kinase Signaling System | 1 | 2007 | 1480 | 0.180 |
Why?
|
| Endopeptidases | 6 | 2006 | 772 | 0.180 |
Why?
|
| Time Factors | 10 | 2021 | 39885 | 0.180 |
Why?
|
| Epitopes | 5 | 2020 | 2497 | 0.180 |
Why?
|
| Transfection | 4 | 2013 | 5783 | 0.170 |
Why?
|
| Societies | 1 | 2020 | 109 | 0.170 |
Why?
|
| Complement C4b | 1 | 2000 | 133 | 0.170 |
Why?
|
| Synaptophysin | 3 | 2016 | 139 | 0.170 |
Why?
|
| Female | 33 | 2024 | 386339 | 0.170 |
Why?
|
| Positron-Emission Tomography | 1 | 2015 | 6472 | 0.170 |
Why?
|
| Clinical Trials as Topic | 6 | 2018 | 7997 | 0.160 |
Why?
|
| Mice, Knockout | 7 | 2017 | 14296 | 0.160 |
Why?
|
| Aspartic Acid Endopeptidases | 6 | 2007 | 310 | 0.160 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2021 | 694 | 0.160 |
Why?
|
| Species Specificity | 4 | 2017 | 2404 | 0.150 |
Why?
|
| Sex Factors | 2 | 2024 | 10454 | 0.150 |
Why?
|
| Neurodegenerative Diseases | 3 | 2017 | 1061 | 0.150 |
Why?
|
| Membrane Proteins | 11 | 2016 | 7814 | 0.150 |
Why?
|
| Immunohistochemistry | 13 | 2015 | 11004 | 0.150 |
Why?
|
| Blotting, Western | 7 | 2009 | 5035 | 0.150 |
Why?
|
| Mutation | 8 | 2024 | 29712 | 0.150 |
Why?
|
| Protons | 1 | 2023 | 1121 | 0.150 |
Why?
|
| ADAM Proteins | 2 | 2010 | 239 | 0.150 |
Why?
|
| Learning | 4 | 2019 | 1727 | 0.140 |
Why?
|
| Gene Expression | 3 | 2007 | 7581 | 0.140 |
Why?
|
| Education | 1 | 2019 | 537 | 0.140 |
Why?
|
| Age Factors | 7 | 2016 | 18302 | 0.140 |
Why?
|
| Inflammation | 7 | 2023 | 10692 | 0.130 |
Why?
|
| Benzimidazoles | 1 | 2021 | 854 | 0.130 |
Why?
|
| Analysis of Variance | 4 | 2012 | 6245 | 0.130 |
Why?
|
| Immunity | 1 | 2022 | 994 | 0.130 |
Why?
|
| Alkaloids | 2 | 2007 | 189 | 0.130 |
Why?
|
| Synapsins | 1 | 2015 | 43 | 0.130 |
Why?
|
| Synaptosomes | 1 | 2015 | 115 | 0.130 |
Why?
|
| Fear | 2 | 2015 | 1447 | 0.130 |
Why?
|
| Solubility | 1 | 2017 | 1083 | 0.130 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2015 | 126 | 0.130 |
Why?
|
| Molecular Chaperones | 1 | 2000 | 743 | 0.130 |
Why?
|
| Amyloidosis | 3 | 2012 | 808 | 0.120 |
Why?
|
| Research Personnel | 1 | 2019 | 580 | 0.120 |
Why?
|
| Immunoprecipitation | 3 | 2013 | 876 | 0.120 |
Why?
|
| Point Mutation | 2 | 1997 | 1591 | 0.120 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2018 | 1337 | 0.120 |
Why?
|
| CHO Cells | 3 | 2013 | 1390 | 0.120 |
Why?
|
| Exploratory Behavior | 1 | 2015 | 262 | 0.120 |
Why?
|
| Nootropic Agents | 1 | 2015 | 156 | 0.120 |
Why?
|
| Random Allocation | 1 | 2019 | 2389 | 0.120 |
Why?
|
| Escherichia coli | 2 | 2005 | 4186 | 0.120 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2015 | 368 | 0.120 |
Why?
|
| Cell Survival | 5 | 2017 | 5775 | 0.110 |
Why?
|
| Glial Fibrillary Acidic Protein | 3 | 2013 | 546 | 0.110 |
Why?
|
| Phenotype | 5 | 2017 | 16440 | 0.110 |
Why?
|
| Cricetinae | 3 | 2013 | 2423 | 0.110 |
Why?
|
| Enzyme Inhibitors | 3 | 2010 | 3703 | 0.110 |
Why?
|
| Dogs | 3 | 2018 | 3840 | 0.110 |
Why?
|
| Immunoenzyme Techniques | 5 | 2002 | 1708 | 0.110 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2013 | 362 | 0.110 |
Why?
|
| Protein Engineering | 1 | 2016 | 544 | 0.100 |
Why?
|
| Drug Discovery | 2 | 2018 | 1057 | 0.100 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2012 | 10798 | 0.100 |
Why?
|
| Immunization, Secondary | 2 | 2006 | 357 | 0.100 |
Why?
|
| Optic Nerve | 1 | 1996 | 565 | 0.100 |
Why?
|
| Neuroblastoma | 3 | 2010 | 1240 | 0.100 |
Why?
|
| Scavenger Receptors, Class A | 1 | 2012 | 52 | 0.100 |
Why?
|
| Age of Onset | 4 | 2013 | 3290 | 0.100 |
Why?
|
| Brain Chemistry | 4 | 2006 | 964 | 0.100 |
Why?
|
| Culture Media, Conditioned | 1 | 2013 | 522 | 0.100 |
Why?
|
| Research | 1 | 2020 | 1962 | 0.100 |
Why?
|
| Phosphorylation | 6 | 2020 | 8314 | 0.100 |
Why?
|
| Receptors, Complement | 1 | 2012 | 253 | 0.100 |
Why?
|
| Microinjections | 1 | 2012 | 321 | 0.100 |
Why?
|
| Astrocytes | 3 | 2017 | 1317 | 0.090 |
Why?
|
| Cerebellum | 3 | 2000 | 1495 | 0.090 |
Why?
|
| Receptors, Immunologic | 1 | 2017 | 1424 | 0.090 |
Why?
|
| Cell Line, Transformed | 1 | 2012 | 874 | 0.090 |
Why?
|
| Lysosomes | 2 | 2012 | 908 | 0.090 |
Why?
|
| Malondialdehyde | 1 | 2010 | 104 | 0.090 |
Why?
|
| S-Adenosylmethionine | 1 | 2012 | 212 | 0.090 |
Why?
|
| Conditioning, Classical | 1 | 2013 | 362 | 0.090 |
Why?
|
| Spatial Behavior | 1 | 2010 | 88 | 0.090 |
Why?
|
| Maleimides | 1 | 2010 | 112 | 0.090 |
Why?
|
| Nerve Regeneration | 1 | 1996 | 781 | 0.090 |
Why?
|
| Long-Term Potentiation | 4 | 2016 | 293 | 0.090 |
Why?
|
| Blood Vessels | 1 | 2015 | 1114 | 0.080 |
Why?
|
| Infusions, Parenteral | 2 | 2015 | 402 | 0.080 |
Why?
|
| Motor Activity | 1 | 2019 | 2683 | 0.080 |
Why?
|
| Signal Transduction | 4 | 2024 | 23235 | 0.080 |
Why?
|
| Exosomes | 1 | 2013 | 422 | 0.080 |
Why?
|
| Cell Proliferation | 3 | 2013 | 10358 | 0.080 |
Why?
|
| Adaptation, Physiological | 1 | 2015 | 1286 | 0.080 |
Why?
|
| Infusion Pumps | 1 | 2009 | 163 | 0.080 |
Why?
|
| Ligands | 2 | 2013 | 3278 | 0.080 |
Why?
|
| Cell Line, Tumor | 4 | 2010 | 16739 | 0.080 |
Why?
|
| Dopamine | 2 | 2007 | 1578 | 0.080 |
Why?
|
| Osteopetrosis | 1 | 2007 | 43 | 0.080 |
Why?
|
| Tauopathies | 1 | 2012 | 313 | 0.080 |
Why?
|
| Disease Progression | 5 | 2018 | 13403 | 0.080 |
Why?
|
| Interleukin-2 | 2 | 2004 | 1868 | 0.070 |
Why?
|
| Receptors, Muscarinic | 1 | 2007 | 156 | 0.070 |
Why?
|
| Dementia | 2 | 2019 | 2588 | 0.070 |
Why?
|
| Aged | 18 | 2021 | 166705 | 0.070 |
Why?
|
| Cerebral Ventricles | 1 | 2009 | 540 | 0.070 |
Why?
|
| Spleen | 1 | 2013 | 2276 | 0.070 |
Why?
|
| Encephalitis | 2 | 2006 | 430 | 0.070 |
Why?
|
| Muscarinic Antagonists | 1 | 2007 | 136 | 0.070 |
Why?
|
| T-Lymphocytes | 3 | 2013 | 10049 | 0.070 |
Why?
|
| Cytoplasmic Granules | 1 | 2009 | 574 | 0.070 |
Why?
|
| Membrane Glycoproteins | 1 | 2017 | 3669 | 0.070 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2007 | 255 | 0.070 |
Why?
|
| Up-Regulation | 4 | 2016 | 4115 | 0.070 |
Why?
|
| Protein Kinase C-alpha | 1 | 2006 | 113 | 0.070 |
Why?
|
| G(M1) Ganglioside | 2 | 2004 | 87 | 0.070 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2007 | 476 | 0.070 |
Why?
|
| Interferon-gamma | 2 | 2004 | 3128 | 0.070 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2007 | 236 | 0.070 |
Why?
|
| Lipid A | 1 | 2005 | 69 | 0.070 |
Why?
|
| Memory | 3 | 2014 | 2176 | 0.060 |
Why?
|
| Forkhead Transcription Factors | 1 | 2013 | 1591 | 0.060 |
Why?
|
| Drug Interactions | 2 | 2008 | 1420 | 0.060 |
Why?
|
| Biophysical Phenomena | 1 | 2006 | 320 | 0.060 |
Why?
|
| Gene Expression Regulation | 6 | 2017 | 11882 | 0.060 |
Why?
|
| Temporal Lobe | 3 | 2009 | 1690 | 0.060 |
Why?
|
| Biophysics | 1 | 2006 | 380 | 0.060 |
Why?
|
| Apoptosis | 4 | 2017 | 9436 | 0.060 |
Why?
|
| Mice, Mutant Strains | 2 | 2007 | 1765 | 0.060 |
Why?
|
| Rats, Wistar | 4 | 2013 | 1839 | 0.060 |
Why?
|
| Rats | 10 | 2013 | 23565 | 0.060 |
Why?
|
| Cells, Cultured | 4 | 2017 | 18918 | 0.060 |
Why?
|
| Interleukin-5 | 1 | 2004 | 266 | 0.060 |
Why?
|
| Administration, Cutaneous | 1 | 2006 | 707 | 0.060 |
Why?
|
| Tandem Repeat Sequences | 1 | 2005 | 182 | 0.060 |
Why?
|
| Cysteine Endopeptidases | 3 | 2003 | 546 | 0.060 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2004 | 1748 | 0.060 |
Why?
|
| Diagnostic Imaging | 1 | 2018 | 3509 | 0.060 |
Why?
|
| Reference Values | 2 | 2002 | 4903 | 0.060 |
Why?
|
| Reaction Time | 1 | 2010 | 2066 | 0.060 |
Why?
|
| Hydroxamic Acids | 1 | 2006 | 481 | 0.060 |
Why?
|
| Animals, Wild | 1 | 2003 | 76 | 0.050 |
Why?
|
| Synucleins | 1 | 2003 | 107 | 0.050 |
Why?
|
| Metabolic Clearance Rate | 1 | 2003 | 363 | 0.050 |
Why?
|
| Cholera Toxin | 1 | 2005 | 558 | 0.050 |
Why?
|
| Enzyme Activation | 2 | 2007 | 3598 | 0.050 |
Why?
|
| Insulin Resistance | 1 | 2017 | 3910 | 0.050 |
Why?
|
| Protein Kinase C | 1 | 2007 | 1199 | 0.050 |
Why?
|
| RNA, Small Interfering | 1 | 2012 | 3447 | 0.050 |
Why?
|
| Animals, Newborn | 2 | 2006 | 2659 | 0.050 |
Why?
|
| Aged, 80 and over | 10 | 2017 | 58347 | 0.050 |
Why?
|
| Phosphotransferases | 1 | 2003 | 306 | 0.050 |
Why?
|
| Gelsolin | 1 | 2003 | 189 | 0.050 |
Why?
|
| Oxidative Stress | 2 | 2010 | 3051 | 0.050 |
Why?
|
| Indoles | 1 | 2010 | 1814 | 0.050 |
Why?
|
| Longevity | 1 | 2009 | 1034 | 0.050 |
Why?
|
| DNA-Binding Proteins | 2 | 2009 | 9554 | 0.050 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2002 | 427 | 0.050 |
Why?
|
| Cell Line | 3 | 2006 | 15636 | 0.050 |
Why?
|
| Interleukin-4 | 1 | 2004 | 1110 | 0.050 |
Why?
|
| Lewy Body Disease | 1 | 2003 | 248 | 0.050 |
Why?
|
| Amyloidogenic Proteins | 1 | 2021 | 150 | 0.050 |
Why?
|
| Neocortex | 1 | 2004 | 420 | 0.040 |
Why?
|
| Complement Membrane Attack Complex | 1 | 2000 | 104 | 0.040 |
Why?
|
| Middle Aged | 15 | 2017 | 217250 | 0.040 |
Why?
|
| Rhenium | 1 | 1999 | 14 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2007 | 2665 | 0.040 |
Why?
|
| Clusterin | 1 | 2000 | 71 | 0.040 |
Why?
|
| Peptides | 2 | 2009 | 4306 | 0.040 |
Why?
|
| Animals, Genetically Modified | 1 | 2004 | 1553 | 0.040 |
Why?
|
| Multienzyme Complexes | 1 | 2003 | 664 | 0.040 |
Why?
|
| Complementarity Determining Regions | 1 | 2020 | 148 | 0.040 |
Why?
|
| Nasal Mucosa | 1 | 2002 | 411 | 0.040 |
Why?
|
| Colitis | 1 | 2008 | 1220 | 0.040 |
Why?
|
| Complement C4 | 1 | 2000 | 244 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2024 | 36038 | 0.040 |
Why?
|
| Isoantibodies | 1 | 2002 | 640 | 0.040 |
Why?
|
| Dietary Supplements | 1 | 2012 | 3369 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2012 | 8449 | 0.040 |
Why?
|
| Haplorhini | 1 | 1999 | 530 | 0.040 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2009 | 1437 | 0.040 |
Why?
|
| Contusions | 1 | 2018 | 79 | 0.040 |
Why?
|
| Codon | 2 | 1997 | 601 | 0.040 |
Why?
|
| Cell Count | 2 | 2018 | 1834 | 0.040 |
Why?
|
| Recombinant Proteins | 1 | 2007 | 6513 | 0.040 |
Why?
|
| Retinal Rod Photoreceptor Cells | 1 | 1999 | 199 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2017 | 8157 | 0.040 |
Why?
|
| MicroRNAs | 1 | 2013 | 3765 | 0.040 |
Why?
|
| Dimerization | 2 | 2008 | 889 | 0.030 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2003 | 1311 | 0.030 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2006 | 1791 | 0.030 |
Why?
|
| Complement Pathway, Classical | 1 | 2016 | 92 | 0.030 |
Why?
|
| Tectum Mesencephali | 1 | 1996 | 19 | 0.030 |
Why?
|
| Goldfish | 1 | 1996 | 65 | 0.030 |
Why?
|
| Bungarotoxins | 1 | 1996 | 46 | 0.030 |
Why?
|
| Immune Sera | 1 | 1996 | 611 | 0.030 |
Why?
|
| Axons | 1 | 1984 | 1666 | 0.030 |
Why?
|
| Horseradish Peroxidase | 1 | 1996 | 165 | 0.030 |
Why?
|
| Edema | 1 | 2020 | 772 | 0.030 |
Why?
|
| Organometallic Compounds | 1 | 1999 | 656 | 0.030 |
Why?
|
| Isoenzymes | 2 | 2001 | 1690 | 0.030 |
Why?
|
| Staining and Labeling | 2 | 1999 | 1092 | 0.030 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2016 | 109 | 0.030 |
Why?
|
| Endocytosis | 1 | 2020 | 975 | 0.030 |
Why?
|
| Phospholipases A | 1 | 1996 | 204 | 0.030 |
Why?
|
| Models, Biological | 3 | 2018 | 9448 | 0.030 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1996 | 489 | 0.030 |
Why?
|
| Cricetulus | 2 | 2008 | 816 | 0.030 |
Why?
|
| Tetrodotoxin | 1 | 1996 | 246 | 0.030 |
Why?
|
| Capillaries | 2 | 2015 | 744 | 0.030 |
Why?
|
| Denervation | 1 | 1996 | 278 | 0.030 |
Why?
|
| Hominidae | 1 | 1994 | 66 | 0.030 |
Why?
|
| Retinopathy of Prematurity | 1 | 1999 | 426 | 0.030 |
Why?
|
| Gene Targeting | 1 | 2017 | 838 | 0.030 |
Why?
|
| PrPC Proteins | 1 | 2013 | 37 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2004 | 8954 | 0.030 |
Why?
|
| Neurites | 1 | 1996 | 383 | 0.030 |
Why?
|
| Cholesterol | 1 | 2003 | 2903 | 0.030 |
Why?
|
| Lymphocyte Activation | 1 | 2004 | 5418 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2015 | 17650 | 0.030 |
Why?
|
| Macrophages | 1 | 2008 | 5690 | 0.030 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 1996 | 656 | 0.030 |
Why?
|
| Cytosol | 1 | 1996 | 881 | 0.030 |
Why?
|
| Child | 5 | 2006 | 78996 | 0.030 |
Why?
|
| Adolescent | 5 | 2006 | 86822 | 0.030 |
Why?
|
| Pericytes | 1 | 2015 | 287 | 0.030 |
Why?
|
| DNA Methylation | 2 | 2017 | 4298 | 0.030 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2013 | 150 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2001 | 1871 | 0.030 |
Why?
|
| Glycoproteins | 1 | 2000 | 2195 | 0.030 |
Why?
|
| Down-Regulation | 2 | 2013 | 2910 | 0.030 |
Why?
|
| Cytoplasm | 2 | 2009 | 1522 | 0.020 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2017 | 811 | 0.020 |
Why?
|
| Diffusion | 1 | 2013 | 810 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 1994 | 639 | 0.020 |
Why?
|
| RNA, Untranslated | 1 | 2015 | 456 | 0.020 |
Why?
|
| Adult | 10 | 2006 | 217168 | 0.020 |
Why?
|
| Cerebrospinal Fluid | 1 | 2013 | 539 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2017 | 2683 | 0.020 |
Why?
|
| AIDS Dementia Complex | 1 | 1991 | 154 | 0.020 |
Why?
|
| Benzothiazoles | 2 | 2004 | 245 | 0.020 |
Why?
|
| Cerebral Arteries | 1 | 1992 | 491 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 2017 | 1948 | 0.020 |
Why?
|
| Congresses as Topic | 1 | 2014 | 795 | 0.020 |
Why?
|
| Hydrogen Peroxide | 1 | 2013 | 725 | 0.020 |
Why?
|
| Parkinson Disease | 1 | 2003 | 2834 | 0.020 |
Why?
|
| Cytoprotection | 1 | 2009 | 200 | 0.020 |
Why?
|
| Autophagy | 1 | 2017 | 1324 | 0.020 |
Why?
|
| Alleles | 1 | 2020 | 6878 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2014 | 2635 | 0.020 |
Why?
|
| Immune Tolerance | 1 | 2017 | 2231 | 0.020 |
Why?
|
| Protein Structure, Quaternary | 1 | 2009 | 429 | 0.020 |
Why?
|
| Monocytes | 1 | 2017 | 2556 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2017 | 2440 | 0.020 |
Why?
|
| Dentate Gyrus | 1 | 2009 | 161 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2006 | 7294 | 0.020 |
Why?
|
| Inclusion Bodies | 1 | 2009 | 279 | 0.020 |
Why?
|
| Protein Binding | 1 | 2020 | 9288 | 0.020 |
Why?
|
| Macaca mulatta | 2 | 2004 | 2306 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2002 | 14601 | 0.020 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2013 | 1114 | 0.020 |
Why?
|
| Oxygen | 1 | 1999 | 4179 | 0.020 |
Why?
|
| Molecular Weight | 1 | 2009 | 2182 | 0.020 |
Why?
|
| Primates | 1 | 2009 | 530 | 0.020 |
Why?
|
| Child, Preschool | 2 | 2002 | 41656 | 0.020 |
Why?
|
| Genes, Dominant | 1 | 2009 | 865 | 0.020 |
Why?
|
| Dendritic Spines | 1 | 2008 | 244 | 0.020 |
Why?
|
| Haplotypes | 1 | 2012 | 2748 | 0.020 |
Why?
|
| Neuropsychological Tests | 2 | 2014 | 6968 | 0.020 |
Why?
|
| Cathepsin L | 2 | 1995 | 68 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2012 | 3585 | 0.020 |
Why?
|
| Leeches | 1 | 1984 | 10 | 0.020 |
Why?
|
| Neprilysin | 1 | 2007 | 464 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2009 | 1693 | 0.010 |
Why?
|
| Chromatography, Gel | 1 | 2005 | 642 | 0.010 |
Why?
|
| Plant Extracts | 1 | 2008 | 495 | 0.010 |
Why?
|
| RNA Interference | 1 | 2013 | 2843 | 0.010 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2004 | 317 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2018 | 9174 | 0.010 |
Why?
|
| Thiazoles | 2 | 2004 | 1504 | 0.010 |
Why?
|
| Neutralization Tests | 1 | 2005 | 728 | 0.010 |
Why?
|
| Molecular Sequence Data | 4 | 1996 | 17608 | 0.010 |
Why?
|
| Frontal Lobe | 1 | 2009 | 1414 | 0.010 |
Why?
|
| Injections, Intraperitoneal | 1 | 2003 | 407 | 0.010 |
Why?
|
| Electrophysiology | 1 | 2005 | 1265 | 0.010 |
Why?
|
| Macaca fascicularis | 1 | 2004 | 904 | 0.010 |
Why?
|
| Neurons, Afferent | 1 | 1984 | 496 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 2004 | 1434 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2017 | 9355 | 0.010 |
Why?
|
| Presenilin-2 | 1 | 2001 | 95 | 0.010 |
Why?
|
| Spinal Cord | 1 | 2009 | 1804 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 2 | 2007 | 5780 | 0.010 |
Why?
|
| Alcoholism | 1 | 1991 | 1936 | 0.010 |
Why?
|
| Liposomes | 1 | 2004 | 772 | 0.010 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2001 | 318 | 0.010 |
Why?
|
| Amino Acid Sequence | 3 | 1996 | 13432 | 0.010 |
Why?
|
| Congo Red | 1 | 1999 | 44 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2012 | 9701 | 0.010 |
Why?
|
| Organotechnetium Compounds | 1 | 1999 | 134 | 0.010 |
Why?
|
| Microspectrophotometry | 1 | 1999 | 4 | 0.010 |
Why?
|
| Rod Cell Outer Segment | 1 | 1999 | 51 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2007 | 2471 | 0.010 |
Why?
|
| Cyclooxygenase 2 | 1 | 2001 | 599 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2009 | 2900 | 0.010 |
Why?
|
| Rod Opsins | 1 | 1999 | 108 | 0.010 |
Why?
|
| Rhodopsin | 1 | 1999 | 203 | 0.010 |
Why?
|
| Pyramidal Cells | 1 | 2000 | 367 | 0.010 |
Why?
|
| Phagosomes | 1 | 1999 | 201 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 4573 | 0.010 |
Why?
|
| Fluorometry | 1 | 1996 | 100 | 0.010 |
Why?
|
| Coloring Agents | 1 | 1999 | 555 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2001 | 2286 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase 5 | 1 | 1996 | 105 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2007 | 4343 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2004 | 3788 | 0.010 |
Why?
|
| Phospholipases A2 | 1 | 1996 | 196 | 0.010 |
Why?
|
| Cathepsin D | 1 | 1995 | 60 | 0.010 |
Why?
|
| Cathepsin B | 1 | 1995 | 80 | 0.010 |
Why?
|
| Vision, Ocular | 1 | 1999 | 454 | 0.010 |
Why?
|
| Lung | 1 | 1994 | 9899 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 1996 | 480 | 0.010 |
Why?
|
| Alanine | 1 | 1997 | 584 | 0.010 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 1996 | 412 | 0.010 |
Why?
|
| Arachidonic Acid | 1 | 1996 | 428 | 0.010 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 1999 | 1069 | 0.010 |
Why?
|
| Golgi Apparatus | 1 | 1995 | 400 | 0.010 |
Why?
|
| Genomic Library | 1 | 1994 | 190 | 0.010 |
Why?
|
| Autopsy | 1 | 1997 | 1006 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1996 | 1537 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 1994 | 366 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2012 | 12451 | 0.010 |
Why?
|
| Sweden | 1 | 1995 | 1378 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2012 | 15645 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 1994 | 453 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 1994 | 534 | 0.010 |
Why?
|
| Pia Mater | 1 | 1992 | 87 | 0.010 |
Why?
|
| Karyotyping | 1 | 1994 | 1182 | 0.010 |
Why?
|
| Arterioles | 1 | 1992 | 250 | 0.010 |
Why?
|
| Glutamic Acid | 1 | 1997 | 1160 | 0.010 |
Why?
|
| Introns | 1 | 1994 | 972 | 0.010 |
Why?
|
| Microtubule-Associated Proteins | 1 | 1996 | 1078 | 0.010 |
Why?
|
| Mass Spectrometry | 1 | 1996 | 2176 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2004 | 12737 | 0.010 |
Why?
|
| HIV Envelope Protein gp41 | 1 | 1991 | 304 | 0.010 |
Why?
|
| Radiopharmaceuticals | 1 | 1999 | 2662 | 0.010 |
Why?
|
| Pedigree | 1 | 1997 | 4573 | 0.010 |
Why?
|
| Organ Specificity | 1 | 1994 | 1954 | 0.010 |
Why?
|
| Headache | 1 | 1997 | 1235 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 1992 | 2561 | 0.010 |
Why?
|
| Exons | 1 | 1994 | 2383 | 0.000 |
Why?
|
| Brain Neoplasms | 1 | 2008 | 8895 | 0.000 |
Why?
|
| Organ Size | 1 | 1991 | 2248 | 0.000 |
Why?
|
| Atrophy | 1 | 1991 | 1611 | 0.000 |
Why?
|
| Chromosome Mapping | 1 | 1994 | 4628 | 0.000 |
Why?
|
| HIV Infections | 1 | 1991 | 17006 | 0.000 |
Why?
|
| HIV | 1 | 1991 | 1579 | 0.000 |
Why?
|
| Base Sequence | 1 | 1994 | 12432 | 0.000 |
Why?
|
| Cell Membrane | 1 | 1992 | 3682 | 0.000 |
Why?
|
| Infant, Newborn | 1 | 1999 | 25910 | 0.000 |
Why?
|